The Galaxy Tab S8 has already won several design awards and for this reason it was chosen to collaborate in the diagnosis and treatment of Alzheimer’s by the Swiss startup Bottneuro AG. The tablet is used as a portable computer to store and record data during tests that used to be complex, but have become simpler thanks to their mobility.
The tablet used is the Galaxy Tab S8 Plus 5G Enterprise Edition, a version of the device aimed at the corporate market that integrates additional security services and remote management, which allows doctors to monitor patient exams remotely, without them having to go to the hospital regularly.
Bottneuro AG’s technology identifies areas of the brain that have been affected by Alzheimer’s by performing 3D magnetic resonance imaging and positron emission tomography. These areas are treated with Miamind neural stimulators connected to the tablet to facilitate their handling by doctors and patients as in the image above.
Julius Klaas, CTO of Bottneuro AG, explains the benefit of using the Galaxy Tab S8 Plus 5G for exams and treatments:
We were looking for a simple and reliable solution for our app. We found this in the Galaxy Tab S8+ 5G Enterprise Edition and Samsung is giving us great support in the development.
Another advantage is that the tablet automatically transmits the collected data to the doctors when the treatment is completed. In this way, it is not necessary for the patient to travel from home to the hospital every day, as the Galaxy Tab S8 Plus has a 5G connection. All data privacy is assured with Samsung Knox protection.
The Samsung Galaxy Tab S8 Plus is not yet available in Europeian stores. To be notified when it arrives click here.